1. Home
  2. CKX vs CNSY Comparison

CKX vs CNSY Comparison

Compare CKX & CNSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

N/A

Current Price

$10.52

Market Cap

23.5M

Sector

Energy

ML Signal

N/A

Logo Cerenome Inc. Common Stock

CNSY

Cerenome Inc. Common Stock

N/A

Current Price

$1.78

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CKX
CNSY
Founded
1930
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.5M
20.6M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
CKX
CNSY
Price
$10.52
$1.78
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $32.50
AVG Volume (30 Days)
3.2K
★ 85.1K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1125.00
87.61
EPS
★ 0.09
N/A
Revenue
$838,543.00
★ $5,213,000.00
Revenue This Year
N/A
$81.07
Revenue Next Year
N/A
$102.79
P/E Ratio
$118.78
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$8.66
$1.86
52 Week High
$13.00
$4.03

Technical Indicators

Market Signals
Indicator
CKX
CNSY
Relative Strength Index (RSI) 44.65 28.54
Support Level $10.23 N/A
Resistance Level $11.71 $3.28
Average True Range (ATR) 0.29 0.14
MACD -0.03 0.02
Stochastic Oscillator 5.88 12.50

Price Performance

Historical Comparison
CKX
CNSY

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way, and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. It has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Timber segment.

About CNSY Cerenome Inc. Common Stock

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.

Share on Social Networks: